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By catalyzing the production of the intracellular signaling
molecule cGMP NO-sensitive guanylyl cyclase (NO-GC),
as the major receptor for NO, has a key function within
the NO/cGMP cascade. The pharmacological importance
of the enzyme is reflected by NO donors used for the ther-
apy of coronary heart disease. NO-GC is made up of one
β subunit and one α subunit. As there are two α subunits
(α1 and α2), two different GC isoforms are known to exist
(α1β1 and α2β1). In the cardiovascular system, vasorelaxa-
tion and inhibition of platelet aggregation are mediated
by the α1β1 GC. As the α2 subunit is mainly found in nerve
cells of the CNS, the α2β1 heterodimer is believed to par-
ticipate in synaptic plasticity. The role of NO-GC in the
gastrointestinal tract is still unclear. NO is contributing to
non-adrenergic non-cholinergic (NANC) relaxation of
gastrointestinal smooth muscle.
Using mice deficient in the β1 subunit we investigated the
role of NO-GC in vascular and intestinal tissues. These
mice do not express any of the α subunits and reveal no
detectable cGMP synthesis upon NO stimulation. Thus
mice lacking the β subunit are in fact total NO-GC knock
out mice. Whereas mice heterozygous for the β1 subunit of
NO-GC were phenotypically undistinguishable from WT,
homozygous GC-KO mice died prematurely. 3-week-old
homozygous GC-KO mice exhibit considerable growth
retardation shown by a 40% reduced body weight. KO
mice surviving until day 18+ are hypertensive and die
from gastrointestinal dysmotility leading to ileus and per-
foration. By substituting normal rodent chow with fiber-
free diet we were able to rescue GC-KO mice.
In order to find out the relative contribution of smooth
muscle cells to the GC-KO phenotype we are currently
investigating smooth muscle specific GC-KO mice
(SMKO). Tamoxifen was used for induction of the tissue-
specific KO. SMKO mice do not reveal the reduced life
expectancy of total GC-KO mice. However, tamoxifen-
injected SMKO animals develop hypertension within sev-
eral weeks. This model of a slowly developing hyperten-
sion further underlines the importance of constitutively
released endothelial NO as major regulator of blood pres-
sure.
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